Recall Register

Device recall: LuSys 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Saliva Test)

Class I FDA enforcement event 89539. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

COVID-19 test kits (Antibody Rapid Test kit and Antigen Rapid Test Kit) are not authorized, cleared, or approved for marketing and/or distribution in the U.S.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

Lusys Laboratories, Inc. started this device recall on 13 Jan 2022. The firm address in the FDA record is in San Diego, CA. FDA put the recall in Class I. FDA event 89539 has 3 product records. The first FDA enforcement report date is 16 Mar 2022. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide - US Nationwide distribution in the states of CA, NC, NV, OH, TN and TX. The countries of Canada, China, and Mexico. Pending additional information for a complete Consignee Listing

Recalling firm

Lusys Laboratories, Inc., San Diego, CA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

3 product records in the event.

FDA event 89539: product records
Recall numberProductQuantityClassStatusReport date
Z-0716-2022LuSys 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Saliva Test)14,745 kitsClass IOngoing16 Mar 2022
Z-0717-2022Luscient Diagnostics 2nd Generation of COVID-19 Viral Antigen Test For all mutant variety Cat: I-114(Nasal Swab Test)90,849 kitsClass IOngoing16 Mar 2022
Z-0718-2022COVID-19 IgG/IGM Antibody Test For Detection of COVID-19 IgG and IgM antibodies Catalog No: I-11133,955 kitsClass IOngoing16 Mar 2022

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Device events that started in 2022
839
Share of these events in Class I
8%
Product records in this event
3Median of the firm: 8
Events of the firm on the register
2

Other events of the firm

Other FDA enforcement events of Lusys Laboratories, Inc.
InitiatedProduct (first record)TypeClassRecords
13 Mar 2015Ebola IgX VP-40 Serum/Plasma/Blood Cassette, Catalog No. I-100 Materials Provided: 1. Test Device 2. Lancet 3. Alcohol pDeviceClass I8

Official channels

Cite this page

Recall Register. FDA enforcement event 89539. https://recallregister.com/fda/i/89539/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide - US Nationwide distribution in the states of CA, NC, NV, OH, TN and TX. The countries of Canada, China, and Mexico. Pending additional information for a complete Consignee Listing
What quantity of product is in FDA event 89539?
The event has 3 product records. The first record gives this quantity: 14,745 kits
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2022 have the same class?
8% of the 839 device events that started in 2022 are in Class I.